Skip to content
Recall Observatory FDA recall evidence

Drug product

Pioglitazone and Metformin Hydrochloride Tablets, USP 15 mg/500 mg, Rx Only, 60-count bottle, Manufactured for Macleods Pharma USA, Inc. Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Himachal Pradesh, India, NDA 33342-176-09

D-0838-2020

January 24, 2020

Class III

Product summary

Firm
Macleods Pharma Usa Inc
Event
Event 84754
Status
Terminated
Classification
Class III
Quantity
4694 30x60-count bottles
Official record key
drug-enforcement:D-0838-2020

Official wording

Reason: Subpotent Drug: Out of specification assay result, below specification, for two lots of Pioglitazone And Metformin Hydrochloride Tablets.

Code information: Lot# BPA5903A, EXP 05/2021; BPA5819A, EXP 11/2020

Distribution pattern: Nationwide

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Subpotent